AGTC is a biotechnology company seeking to transform the lives of patients with rare and debilitating eye diseases through its proprietary gene therapy platform...
Our team includes industry-leading experts and innovative thinkers working together on discoveries that we hope will transform the lives of people with rare inherited eye disorders. In particular, we are studying how to use our gene therapy platform to develop investigational treatments for disorders that are caused by single-gene mutations and that also have a significant effect on a person's sight.